Annual D&A
$7100.00
-$179.30 K-96.19%
December 31, 2023
Summary
- As of February 23, 2025, APRE annual depreciation & amortization is $7100.00, with the most recent change of -$179.30 thousand (-96.19%) on December 31, 2023.
- During the last 3 years, APRE annual D&A has fallen by -$222.50 thousand (-96.91%).
- APRE annual D&A is now -99.25% below its all-time high of $947.10 thousand, reached on June 1, 2006.
Performance
APRE Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$5400.00
+$100.00+1.89%
September 30, 2024
Summary
- As of February 23, 2025, APRE quarterly depreciation & amortization is $5400.00, with the most recent change of +$100.00 (+1.89%) on September 30, 2024.
- Over the past year, APRE quarterly D&A has stayed the same.
- APRE quarterly D&A is now -92.89% below its all-time high of $76.00 thousand, reached on March 31, 2021.
Performance
APRE Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$21.90 K
+$4000.00+22.35%
September 30, 2024
Summary
- As of February 23, 2025, APRE TTM depreciation & amortization is $21.90 thousand, with the most recent change of +$4000.00 (+22.35%) on September 30, 2024.
- Over the past year, APRE TTM D&A has stayed the same.
- APRE TTM D&A is now -91.94% below its all-time high of $271.60 thousand, reached on December 31, 2021.
Performance
APRE TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
APRE Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -96.2% | 0.0% | 0.0% |
| 3 y3 years | -96.9% | 0.0% | 0.0% |
| 5 y5 years | -14.5% | 0.0% | 0.0% |
APRE Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -97.4% | at low | -91.8% | +325.0% | -91.9% | +5575.0% |
| 5 y | 5-year | -97.4% | at low | -92.9% | +325.0% | -91.9% | +5575.0% |
| alltime | all time | -99.3% | at low | -92.9% | +325.0% | -91.9% | +5575.0% |
Aprea Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $5400.00(+1.9%) | $21.90 K(+22.3%) |
| Jun 2024 | - | $5300.00(-14.5%) | $17.90 K(+39.8%) |
| Mar 2024 | - | $6200.00(+24.0%) | $12.80 K(+82.9%) |
| Dec 2023 | $7100.00(-96.2%) | $5000.00(+257.1%) | $7000.00(-1850.0%) |
| Sep 2023 | - | $1400.00(+600.0%) | -$400.00(-100.7%) |
| Jun 2023 | - | $200.00(-50.0%) | $59.60 K(-51.6%) |
| Mar 2023 | - | $400.00(-116.7%) | $123.10 K(-34.0%) |
| Dec 2022 | $186.40 K(-31.4%) | -$2400.00(-103.9%) | $186.50 K(-26.8%) |
| Sep 2022 | - | $61.40 K(-3.6%) | $254.90 K(-3.0%) |
| Jun 2022 | - | $63.70 K(-0.2%) | $262.90 K(+1.3%) |
| Mar 2022 | - | $63.80 K(-3.3%) | $259.40 K(-4.5%) |
| Dec 2021 | $271.70 K | $66.00 K(-4.9%) | $271.60 K(+3.5%) |
| Sep 2021 | - | $69.40 K(+15.3%) | $262.50 K(+5.1%) |
| Jun 2021 | - | $60.20 K(-20.8%) | $249.80 K(+5.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $76.00 K(+33.6%) | $237.90 K(+3.6%) |
| Dec 2020 | $229.60 K(+34.8%) | $56.90 K(+0.4%) | $229.70 K(+2.2%) |
| Sep 2020 | - | $56.70 K(+17.4%) | $224.70 K(-2.2%) |
| Jun 2020 | - | $48.30 K(-28.8%) | $229.80 K(+9.3%) |
| Mar 2020 | - | $67.80 K(+30.6%) | $210.20 K(+23.4%) |
| Dec 2019 | $170.30 K(+1951.8%) | $51.90 K(-16.0%) | $170.30 K(+43.8%) |
| Sep 2019 | - | $61.80 K(+115.3%) | $118.40 K(+109.2%) |
| Jun 2019 | - | $28.70 K(+2.9%) | $56.60 K(+102.9%) |
| Mar 2019 | - | $27.90 K | $27.90 K |
| Dec 2018 | $8300.00(+5.1%) | - | - |
| Dec 2017 | $7900.00(-82.1%) | - | - |
| Jun 2008 | $44.20 K(-88.9%) | - | - |
| Jun 2007 | $397.10 K(-58.1%) | - | - |
| Jun 2006 | $947.10 K | - | - |
FAQ
- What is Aprea Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Aprea Therapeutics?
- What is Aprea Therapeutics annual D&A year-on-year change?
- What is Aprea Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Aprea Therapeutics?
- What is Aprea Therapeutics quarterly D&A year-on-year change?
- What is Aprea Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Aprea Therapeutics?
- What is Aprea Therapeutics TTM D&A year-on-year change?
What is Aprea Therapeutics annual depreciation & amortization?
The current annual D&A of APRE is $7100.00
What is the all time high annual D&A for Aprea Therapeutics?
Aprea Therapeutics all-time high annual depreciation & amortization is $947.10 K
What is Aprea Therapeutics annual D&A year-on-year change?
Over the past year, APRE annual depreciation & amortization has changed by -$179.30 K (-96.19%)
What is Aprea Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of APRE is $5400.00
What is the all time high quarterly D&A for Aprea Therapeutics?
Aprea Therapeutics all-time high quarterly depreciation & amortization is $76.00 K
What is Aprea Therapeutics quarterly D&A year-on-year change?
Over the past year, APRE quarterly depreciation & amortization has changed by $0.00 (0.00%)
What is Aprea Therapeutics TTM depreciation & amortization?
The current TTM D&A of APRE is $21.90 K
What is the all time high TTM D&A for Aprea Therapeutics?
Aprea Therapeutics all-time high TTM depreciation & amortization is $271.60 K
What is Aprea Therapeutics TTM D&A year-on-year change?
Over the past year, APRE TTM depreciation & amortization has changed by $0.00 (0.00%)